Nobel Prize for Medicine goes to cancer breakthrough pair
James P. Allison and Tasuku Honjo awarded the prestigious prize for ‘exciting and groundbreaking’ work in immunotherapy
Two immunologists have been awarded the 2018 Nobel Prize in Medicine for their revolutionary research into cancer treatment.
James P. Allison, based at the MD Anderson Cancer Center in Houston, Texas, and Japan’s Tasuku Honjo, from Kyoto University, are being given the prize for their “exciting and groundbreaking work on developing new types of immunotherapy that help our immune system fight cancer”, writes Sheena Cruickshank, a professor in biomedical sciences at Manchester University, in an article on The Conversation.
As The Guardian explains, the human immune system “normally seeks out and destroys mutated cells, but cancer finds sophisticated ways to hide from immune attacks”, in part by “ramping up braking mechanisms designed to prevent immune cells from attacking normal tissue”.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Allison discovered the first of these built-in brakes, known as checkpoints, in the course of his immunology research in the early 1990s. But while other teams were investigating the potential of enhancing the action of checkpoints to treat autoimmune diseases, Allison was able to demonstrate that by disabling the brakes, medical experts could produce tangible results in treating cancer in mice.
Meanwhile, in 1992, Honjo independently discovered a second checkpoint, and conducted similar experiments.
The pair’s research led to a new approach, known as immune checkpoint theory, that has amounted to a “landmark in our fight against cancer”, the Sweden-based Nobel Committee said. Allison and Honjo have “revolutionised cancer treatment” and “fundamentally changed the way we view how cancer can be managed”, the five-strong panel continued.
The Guardian reports that the scientists’ discoveries have “paved the way for a new class of cancer drugs that are already dramatically changing outcomes for patients”.
After being informed yesterday that he had jointly won the prize, Allison told reporters in Houston: “I’m still in sort of a state of shock, and this is all still sinking in. I was told by the Nobel Committee when I was called this morning that this was the first prize they’ve ever given for cancer therapy.
“I'd like to just give a shout out to all the patients out there who are suffering from cancer to let them know that we are making progress now.”
Honjo, who began his research after a medical school classmate died from stomach cancer, said: “I want to continue my research so that this immune therapy will save more cancer patients than ever.”
Allison and Honjo will be honoured at an official Nobel ceremony in Stockholm in December, and will share the nine million Swedish kronor (£775,000) prize money.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Today's political cartoons - November 23, 2024
Cartoons Saturday's cartoons - qualifications, tax cuts, and more
By The Week US Published
-
Long summer days in Iceland's highlands
The Week Recommends While many parts of this volcanic island are barren, there is a 'desolate beauty' to be found in every corner
By The Week UK Published
-
The Democrats: time for wholesale reform?
Talking Point In the 'wreckage' of the election, the party must decide how to rebuild
By The Week UK Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published
-
The alarming rise of cancer in young people
Under the radar Cancer rates are rising, and the cause is not clear
By Devika Rao, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
'Beyond belief': fears of asbestos return
Under the radar Attention is returning to the dangers of the carcinogenic substance
By Chas Newkey-Burden, The Week UK Published
-
What to say to someone who has cancer
The Explainer Saying something is better than nothing but there are some things to avoid too
By Chas Newkey-Burden, The Week UK Published
-
Anastrozole: the daily breast cancer pill tipped to save thousands of lives
The Explainer Existing treatment approved for preventative use under 'pioneering' NHS drug repurposing scheme
By Harriet Marsden, The Week UK Published
-
Good health news: seven surprising medical discoveries made in 2023
In Depth A fingerprint test for cancer, a menopause patch and the shocking impacts of body odour are just a few of the developments made this year
By The Week Staff Published
-
Five good-news cancer breakthroughs in 2023
In Depth Cancer-sniffing ants, ‘Bond villain’ DNA, and vaccine trials are just a few exciting developments in cancer research this year
By The Week Staff Published